Log in to save to my catalogue

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphosph...

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphosph...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1179_2295333714Y_0000000060

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis

About this item

Full title

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis

Publisher

England: Taylor & Francis

Journal title

Acta clinica belgica (English ed. Online), 2014-12, Vol.69 (6), p.433-438

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Objectives:
The aim of our study was to evaluate the clinical values of anti-beta2 glycoprotein I antibodies (anti-beta2GPI) IgG and IgM comparing with lupus anticoagulant (LA), anticardiolipin antibodies (aCL) in the two clinical groups of antiphospholipid syndrome (APS), vascular thrombosis (VT) and pregnancy morbidity (PM).
Methods:
Eig...

Alternative Titles

Full title

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1179_2295333714Y_0000000060

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1179_2295333714Y_0000000060

Other Identifiers

ISSN

1784-3286

E-ISSN

2295-3337

DOI

10.1179/2295333714Y.0000000060

How to access this item